Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G D Long

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Cancer|September 1, 1995
Multiple cycles of high dose chemotherapy supported by hematopoietic progenitor cells as treatment for patients with advanced malignanciesG D Long, R S Negrin, C F Hoyle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancerW W Hu, G D Long, K E Stockerl-Goldstein, et al.
Cancer|March 15, 1995
A new preparatory regimen for autologous bone marrow transplantation for patients with lymphomaN J Chao, H Kastrissios, G D Long, et al.
Blood|May 15, 1994
A randomized study of erythropoietin and granulocyte colony-stimulating factor (G-CSF) versus placebo and G-CSF for patients with Hodgkin's and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantationN J Chao, J R Schriber, G D Long, et al.
Blood|January 12, 2001
High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trialS J Horning, R S Negrin, R T Hoppe, et al.
Blood|September 1, 1994
Granulocyte colony-stimulating factor after allogeneic bone marrow transplantationJ R Schriber, N J Chao, G D Long, et al.
Bone Marrow Transplantation|November 15, 2011
Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administrationM E Horwitz, J P Chute, C Gasparetto, et al.
Blood|January 15, 1993
Busulfan/etoposide--initial experience with a new preparatory regimen for autologous bone marrow transplantation in patients with acute nonlymphoblastic leukemiaN J Chao, A S Stein, G D Long, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
The Stanford experience with high-dose etoposide cytoreductive regimens and autologous bone marrow transplantation in Hodgkin's disease and non-Hodgkin's lymphoma: preliminary dataS J Horning, N J Chao, R S Negrin, et al.
Bone Marrow Transplantation|October 31, 2017
High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myelomaD Sivaraj, W Bacon, G D Long, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Cancer|September 1, 1995
Multiple cycles of high dose chemotherapy supported by hematopoietic progenitor cells as treatment for patients with advanced malignanciesG D Long, R S Negrin, C F Hoyle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancerW W Hu, G D Long, K E Stockerl-Goldstein, et al.
Cancer|March 15, 1995
A new preparatory regimen for autologous bone marrow transplantation for patients with lymphomaN J Chao, H Kastrissios, G D Long, et al.
Blood|May 15, 1994
A randomized study of erythropoietin and granulocyte colony-stimulating factor (G-CSF) versus placebo and G-CSF for patients with Hodgkin's and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantationN J Chao, J R Schriber, G D Long, et al.
Blood|January 12, 2001
High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trialS J Horning, R S Negrin, R T Hoppe, et al.
Blood|September 1, 1994
Granulocyte colony-stimulating factor after allogeneic bone marrow transplantationJ R Schriber, N J Chao, G D Long, et al.
Bone Marrow Transplantation|November 15, 2011
Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administrationM E Horwitz, J P Chute, C Gasparetto, et al.
Blood|January 15, 1993
Busulfan/etoposide--initial experience with a new preparatory regimen for autologous bone marrow transplantation in patients with acute nonlymphoblastic leukemiaN J Chao, A S Stein, G D Long, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
The Stanford experience with high-dose etoposide cytoreductive regimens and autologous bone marrow transplantation in Hodgkin's disease and non-Hodgkin's lymphoma: preliminary dataS J Horning, N J Chao, R S Negrin, et al.
Bone Marrow Transplantation|October 31, 2017
High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myelomaD Sivaraj, W Bacon, G D Long, et al.
Pageof 6